Latest Mycobacterium smegmatis Stories
An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection.
Scientists at the Albert Einstein College of Medicine reported on Sunday that a vaccine they developed for tuberculosis had shown promising results during early laboratory testing in mice.
Mycobacterium smegmatis is 3.0 to 5.0 Âµm long with a bacillus shape, an acid-fast bacterial species in the phylum Actinobacteria. It can be stained by Ziehl-Neelsen method and the auramine-rhodamine fluorescent method. It was first reported in 1884. Alvarez and Tavel found organisms similar to Lustgarten, who first discovered Mycobacterium. This organism was later named M. smegmatis. It is considered a non-pathogenic microorganism although, in rare cases, it can cause disease. M....
- A serpent whose bite was fabled to produce intense thirst.